possible risk of serious infection with the new rheumatoid arthritis drug, Enbrel (etanercept)

The FDA is warning about a possible risk of serious infection with the new rheumatoid arthritis drug, Enbrel (etanercept).

There are 30 reports of serious infections...including 6 deaths.

Enbrel works by binding tumor necrosis factor (TNF)...a protein that leads to joint pain and inflammation.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote